PCDH9-AS4

Across TCGA pan-cancer cohorts, PCDH9-AS4 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of PCDH9-AS4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where PCDH9-AS4 RNA is repressed in tumor relative to normal tissue. In most cancer types PCDH9-AS4 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

KIRP are the cancer types where PCDH9-AS4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PCDH9-AS4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	−0.019	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

PCDH9-AS4–KIRP

Open the KIRP breakdown →